【摘要】 目的　观察降纤酶治疗急性脑梗死的疗效。　方法　将 57例急性脑梗死病人随机分为治疗组和对照组。治疗组 37例 (男性 2 8例 ,女性 9例 ,年龄 60 .59± 9.4 6岁 ) ,首次用降纤酶 1 0 u加入 0 .9%氯化钠 2 50 ml静脉滴注 ,以后 5u静脉滴注 ,即第 1、 3、 7、 1 1天给药 ,共 4次 ,总剂量 2 5u。对照组 2 0例(男性 1 2例 ,女性 8例 ,年龄 59.55± 1 2 .1 1岁 ) ,用脉通 50 0 ml,每天静脉滴注 1次 ,连用 2周。　结果　治疗组有效率为 91 % ,对照组有效率为 70 % (P <0 .0 5)。　结论　降纤酶是治疗急性脑梗死安全、有效的药物更多还原

【Abstract】 Objective To observe the efficacy of defibrase in the treatment of cerebral infarction Methods Patients(n=57) with cerebral infarction were randomly divided into 2 groupsPatients(n=37) as treatment group(male 28,female 9,age 6059±946) were treated with defibrase 10u added to 09% sodium chlorid 250ml,at first,iv drip,then 5u iv drip other day,that were given at 1,3,7,11 day,altogether four times,25uhe other 20 patients in rheomacrodex group(male 12,female 8,age 5955±1211) were treated with rheomacrodex 500ml iv drip,qd for 2 weeks Results The clinical effective rate was 91% in defibrase group while 70% in rheomacrodex groupThere was significant difference between the group(P<005) Conclusion Defibrase is safe and effective drug for the treatment of cerebral infarction更多还原